Baltimore, MDNCT03201094Now EnrollingIRB Ready

Subarachnoid Hemorrhage Clinical Trial in Baltimore, MD

Access cutting-edge subarachnoid hemorrhage treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.

Sponsored by University of Maryland, Baltimore

Quick Self-Assessment

See if you qualify for this Baltimore location

Preparing your pre-screening questions…

Expert Care in Baltimore

Access subarachnoid hemorrhage specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related subarachnoid hemorrhage treatment provided free

Apply for This Baltimore Location

Check if you qualify for this subarachnoid hemorrhage clinical trial in Baltimore, MD

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Baltimore

    Convenient for MD residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Baltimore site if eligible
  4. 4Begin participation

About This Subarachnoid Hemorrhage Study in Baltimore

The study purpose is to investigate the hypothesis that in adults with SAH, early neuromuscular electrical stimulation (NMES) and high protein supplementation (HPRO) will improve muscle mass, metabolic and inflammatory biomarker profiles, compared to SAH controls receiving standard of care interventions for nutrition and mobilization. The investigators will accomplish this by studying the effects of a high protein (HPRO) nutritional treatment as well as NMES intervention have upon muscle wasting and motor strength acutely after SAH. This will be addressed in a prospective trial of SAH patients receiving HRPO with NMES as compared to age and severity-matched SAH patients undergoing standard of care interventions for nutrition and mobilization. Additionally, the study will investigate the impact HPRO and NMES interventions have upon inflammatory cytokines and markers of energy balance. Results of this study will establish evidence for precision nutrition plus early exercise to mitigate the catabolic and inflammatory state produced by SAH to improve muscle, metabolic, and health recovery outcomes.

Sponsor: University of Maryland, Baltimore

Who Can Participate

Inclusion Criteria

. Being diagnosed with aneurysmal SAH
. Aneurysmal repair within 48 hours of ictus.
. Age between 25 and 80 years old. (\>=25 years old and \<=80 years old)
. Expected stay in the NCCU \> 72 hours.
. Admission Hunt Hess Grade \>=2.
modified Fisher score \>1.

Exclusion Criteria

. Subjects diagnosed with SAH from trauma, rupture of an arteriovenous malformation, neoplasm, vasculitis, or other secondary causes;
. Unlikely to survive one week post hemorrhage either due to impending brain death or likely request for withdrawal of care;
. Unlikely to remain in the ICU for more than 7 days;
. Body mass index \< 15 or \>40 kg/m2;
. Allergy to whey protein;
. Evidence of lower extremity paresis or spasticity within 48 hours of injury
. Pre-morbid modified Rankin Score \>1.
. Known pregnancy
. Presence of active malignancy
. Diagnosis of an inflammatory disorder
. Presence of a neuromuscular disorder
. Diagnosis of chronic renal insufficiency or acute kidney injury (GFR \< 30 mL/min/1.73m2)
. Hepatic insufficiency defined as AST/ALT levels \>2.5 above normal upper limits.
. On-going seizure activity as assessed clinically or by electrographic detection on continuous electroencephalogram (cEEG) at time of enrollment
. Prisoner.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baltimore?

Yes, this clinical trial (NCT03201094) has an active research site in Baltimore, MD that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Subarachnoid Hemorrhage Treatment Options in Baltimore, MD

If you're searching for subarachnoid hemorrhage treatment options in Baltimore, MD, this clinical trial (NCT03201094) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced subarachnoid hemorrhage specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all subarachnoid hemorrhage clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Baltimore, MD

See all rheumatoid arthritis clinical trials recruiting in Baltimore — not just this study.

Browse Rheumatoid Arthritis Trials in Baltimore →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Baltimore?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Baltimore, MD